Warning letter
Novabay Pharmaceuticals Inc: warning letter of Nov 2, 2020
FDA warning letter 610816
Key facts
| Reference number | 610816 |
|---|---|
| Company | Novabay Pharmaceuticals Inc |
| Issue date | Nov 2, 2020 |
| Posted date | Nov 3, 2020 |
| Product type | Drugs |
| Country | 1 |
| Letter on fda.gov | fda.gov |
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: